Carmell Therapeutics Ownership 2024 | Who Owns Carmell Therapeutics Now?
Insider Ownership
33.64%
Carmell Therapeutics Mutual Fund Holders
Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
---|---|---|---|---|---|
FIDELITY CONCORD STREET TRUST | 0.00% | 89,014 | 26,980 | 43.49% | Feb 29, 2024 |
VANGUARD INDEX FUNDS | 0.00% | 170,006 | -164,162 | -49.13% | Mar 31, 2024 |
USAA MUTUAL FUNDS TRUST | 0.00% | 1,749 | - | - | Jan 31, 2024 |
Carmell Therapeutics's largest mutual fund holder by % of total assets is "FIDELITY CONCORD STREET TRUST", owning 89.01K shares, compromising 0.00% of its total assets.
Carmell Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
---|
All Insider Owners Trades
The last insider buy of CTCX was made by Upton Richard A on Jun 14 2024, buying 2,000 shares at $2.20 per share (worth $4.41K).
Carmell Therapeutics Insider Ownership Trends
All Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q2 2024 | 13 | - | - |
Q3 2021 | 2 | - | - |
13 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Carmell Therapeutics's insiders, as of Q2 2024.
Open Market Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q2 2024 | 13 | - | - |
Q3 2021 | - | - | - |
As of Q2 2024, Insider owners conducted 13 open market buy trades and 0 open market sell trades of Carmell Therapeutics's stocks.